Impairment in Glucose Homeostasis Among Obese Adolescents in High Risk Diabetes Prone Population - Jisr Az-Zarqa Village

This study is currently recruiting participants.
Verified February 2012 by Meir Medical Center
Sponsor:
Information provided by (Responsible Party):
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01535105
First received: February 14, 2012
Last updated: March 13, 2013
Last verified: February 2012
  Purpose

Obesity is increasing all over the world in adults, adolescents and children,and is followed by morbidity, including the metabolic syndrome.

Hypothesis: Among obese adolescents there is a subgroup with impaired glucose homeostasis

The aim of the study is to identify adolescents with impaired glucose metabolism, 12-18 years, among high risk diabetes prone population, for diagnosis and treatment.


Condition
Glucose Metabolism Disorders

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by Meir Medical Center:

Primary Outcome Measures:
  • Frequency of Impaired Glucose Homeostasis among obese adolescents in high risk diabetes prone population [ Time Frame: one year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Description of the metabolic profile in obese adolescents [ Time Frame: One year ] [ Designated as safety issue: No ]

Estimated Enrollment: 300
Study Start Date: August 2012
Estimated Study Completion Date: April 2017
Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
Obese Adolescents

  Eligibility

Ages Eligible for Study:   12 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Subjects of the study will be selected from a primary care clinic

Criteria

Inclusion Criteria:

  • Clinical diagnosis of obesity

Exclusion Criteria:

  • History of disease or drug therapy affecting glucose metabolism
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01535105

Contacts
Contact: Nehama Zuckerman-Levin, MD 972-524354143 zuckerln@netvision.net.il

Locations
Israel
Clalit Health Services Clinic Recruiting
Jisr az-Zarqa village, Israel
Contact: Nehama Zuckerman-Levin, MD    072524354143    zuckerln@netvision.net.il   
Principal Investigator: Nehama Zuckerman-Levin, MD         
Sponsors and Collaborators
Meir Medical Center
Investigators
Principal Investigator: Nehama Zuckerman-Levin, MD Clalit Health Services
  More Information

No publications provided

Responsible Party: Meir Medical Center
ClinicalTrials.gov Identifier: NCT01535105     History of Changes
Other Study ID Numbers: Gl homeostasis and obesity
Study First Received: February 14, 2012
Last Updated: March 13, 2013
Health Authority: Israel: Ethics Commission

Additional relevant MeSH terms:
Metabolic Diseases
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on April 15, 2014